Comparing the effects of tocotrienol-rich fraction, calcium and estrogen on bone metabolism in ovariectomized rats

Translated title of the contribution: Membandingkan kesan antara fraksi-kaya tokotrienol, kalsium dan estrogen terhadap metabolisme tulang tikus terovariektomi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Previous studies showed the role of oxidative stress in the pathogenesis of osteoporosis. Thus antioxidant agents have the potential to be used in the treatment and prevention of osteoporosis. In this study, vitamin E in the form of tocotrienol-rich fraction (TRF) was used. Comparison of the effects of treatments was made among TRF, calcium and estrogen. A total of 48 female Sprague-Dawley rats were divided into six groups: baseline, sham-operated, ovariectomized control and ovariectomized given calcium, estrogen or TRF. The treatment agents were administered via oral gavage for two months. Bone histomorphometry showed that treatment with either calcium, estrogen or tocotrienol was able to increase the trabecular volume and reduce the distance between the trabecular bone significantly compared with the ovariectomy control group. Treatment with either estrogen or tocotrienol showed significant increase in the thickness of the trabecular compared with the control group. Based on the calcium content test, supplementation with calcium increased the levels of calcium content in the fourth vertebral lumbar significantly compared with the sham and ovariectomy group. In conclusion, calcium, estrogen and tocotrienol had positive effects on the trabecular bone. However, tocotrienol was more superior to calcium or estrogen in preventing bone loss in postmenopausal osteoporosis. Tocotrienol prevented bone thinning and loss of volume without the side effects as estrogen. Although calcium can improve the bone calcium content, still, it was unable to prevent bone thinning.

Original languageUndefined/Unknown
Pages (from-to)1591-1597
Number of pages7
JournalSains Malaysiana
Volume42
Issue number11
Publication statusPublished - Nov 2013

Fingerprint

Tocotrienols
Estrogens
Calcium
Bone and Bones
Ovariectomy
Osteoporosis
Control Groups
Postmenopausal Osteoporosis
Vitamin E
Sprague Dawley Rats
Oxidative Stress
Antioxidants

Keywords

  • Bone mineral content
  • Estrogen
  • Osteoporosis
  • Structural histomorphometry
  • Tocotrienol
  • Vitamin E

ASJC Scopus subject areas

  • General

Cite this

@article{9a0932b9919a4f678b76f5453618022c,
title = "Comparing the effects of tocotrienol-rich fraction, calcium and estrogen on bone metabolism in ovariectomized rats",
abstract = "Previous studies showed the role of oxidative stress in the pathogenesis of osteoporosis. Thus antioxidant agents have the potential to be used in the treatment and prevention of osteoporosis. In this study, vitamin E in the form of tocotrienol-rich fraction (TRF) was used. Comparison of the effects of treatments was made among TRF, calcium and estrogen. A total of 48 female Sprague-Dawley rats were divided into six groups: baseline, sham-operated, ovariectomized control and ovariectomized given calcium, estrogen or TRF. The treatment agents were administered via oral gavage for two months. Bone histomorphometry showed that treatment with either calcium, estrogen or tocotrienol was able to increase the trabecular volume and reduce the distance between the trabecular bone significantly compared with the ovariectomy control group. Treatment with either estrogen or tocotrienol showed significant increase in the thickness of the trabecular compared with the control group. Based on the calcium content test, supplementation with calcium increased the levels of calcium content in the fourth vertebral lumbar significantly compared with the sham and ovariectomy group. In conclusion, calcium, estrogen and tocotrienol had positive effects on the trabecular bone. However, tocotrienol was more superior to calcium or estrogen in preventing bone loss in postmenopausal osteoporosis. Tocotrienol prevented bone thinning and loss of volume without the side effects as estrogen. Although calcium can improve the bone calcium content, still, it was unable to prevent bone thinning.",
keywords = "Bone mineral content, Estrogen, Osteoporosis, Structural histomorphometry, Tocotrienol, Vitamin E",
author = "Norliza Muhammad and Surayya Razali and Shuid, {Ahmad Nazrun} and Norazlina Mohamed and Soelaiman, {Ima Nirwana}",
year = "2013",
month = "11",
language = "Undefined/Unknown",
volume = "42",
pages = "1591--1597",
journal = "Sains Malaysiana",
issn = "0126-6039",
publisher = "Penerbit Universiti Kebangsaan Malaysia",
number = "11",

}

TY - JOUR

T1 - Comparing the effects of tocotrienol-rich fraction, calcium and estrogen on bone metabolism in ovariectomized rats

AU - Muhammad, Norliza

AU - Razali, Surayya

AU - Shuid, Ahmad Nazrun

AU - Mohamed, Norazlina

AU - Soelaiman, Ima Nirwana

PY - 2013/11

Y1 - 2013/11

N2 - Previous studies showed the role of oxidative stress in the pathogenesis of osteoporosis. Thus antioxidant agents have the potential to be used in the treatment and prevention of osteoporosis. In this study, vitamin E in the form of tocotrienol-rich fraction (TRF) was used. Comparison of the effects of treatments was made among TRF, calcium and estrogen. A total of 48 female Sprague-Dawley rats were divided into six groups: baseline, sham-operated, ovariectomized control and ovariectomized given calcium, estrogen or TRF. The treatment agents were administered via oral gavage for two months. Bone histomorphometry showed that treatment with either calcium, estrogen or tocotrienol was able to increase the trabecular volume and reduce the distance between the trabecular bone significantly compared with the ovariectomy control group. Treatment with either estrogen or tocotrienol showed significant increase in the thickness of the trabecular compared with the control group. Based on the calcium content test, supplementation with calcium increased the levels of calcium content in the fourth vertebral lumbar significantly compared with the sham and ovariectomy group. In conclusion, calcium, estrogen and tocotrienol had positive effects on the trabecular bone. However, tocotrienol was more superior to calcium or estrogen in preventing bone loss in postmenopausal osteoporosis. Tocotrienol prevented bone thinning and loss of volume without the side effects as estrogen. Although calcium can improve the bone calcium content, still, it was unable to prevent bone thinning.

AB - Previous studies showed the role of oxidative stress in the pathogenesis of osteoporosis. Thus antioxidant agents have the potential to be used in the treatment and prevention of osteoporosis. In this study, vitamin E in the form of tocotrienol-rich fraction (TRF) was used. Comparison of the effects of treatments was made among TRF, calcium and estrogen. A total of 48 female Sprague-Dawley rats were divided into six groups: baseline, sham-operated, ovariectomized control and ovariectomized given calcium, estrogen or TRF. The treatment agents were administered via oral gavage for two months. Bone histomorphometry showed that treatment with either calcium, estrogen or tocotrienol was able to increase the trabecular volume and reduce the distance between the trabecular bone significantly compared with the ovariectomy control group. Treatment with either estrogen or tocotrienol showed significant increase in the thickness of the trabecular compared with the control group. Based on the calcium content test, supplementation with calcium increased the levels of calcium content in the fourth vertebral lumbar significantly compared with the sham and ovariectomy group. In conclusion, calcium, estrogen and tocotrienol had positive effects on the trabecular bone. However, tocotrienol was more superior to calcium or estrogen in preventing bone loss in postmenopausal osteoporosis. Tocotrienol prevented bone thinning and loss of volume without the side effects as estrogen. Although calcium can improve the bone calcium content, still, it was unable to prevent bone thinning.

KW - Bone mineral content

KW - Estrogen

KW - Osteoporosis

KW - Structural histomorphometry

KW - Tocotrienol

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=84887716799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887716799&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84887716799

VL - 42

SP - 1591

EP - 1597

JO - Sains Malaysiana

JF - Sains Malaysiana

SN - 0126-6039

IS - 11

ER -